---
type: "NewsArticle"
title: "A machine-learning model estimated future cognitive impairment in Parkinson’s disease"
description: "A retrospective study reported AUCs of 0.822 internally and 0.742 in an external cohort for a TabPFN model. The authors say prospective multicenter validation is needed before clinical use."
resource: "https://nootropikler.com/news/parkinsons-tabpfn-cognitive-impairment-prediction"
tags: ["research", "brain", "cognition"]
timestamp: 2026-10-05T14:46:07Z
language: "en"
---

# A machine-learning model estimated future cognitive impairment in Parkinson’s disease

A retrospective study reported AUCs of 0.822 internally and 0.742 in an external cohort for a TabPFN model. The authors say prospective multicenter validation is needed before clinical use.

Author: Nootropik News Editorial Team
Published: 2026-10-05T14:46:07Z
Update: 2026-10-05T14:46:07Z
News/source date: 2026-09-30
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

The retrospective analysis began with 91 people with Parkinson’s disease who were cognitively normal; 45 developed impairment during follow-up. Researchers trained a TabPFN model on routine clinical and laboratory data and tested it in the independent PPMI cohort.

## What the study found

The model’s area under the curve was 0.822 in internal validation and 0.742 in external validation. Age and baseline cognitive score were influential predictors; triglyceride measures also contributed. Separate analyses found differing triglyceride trajectories between participants who developed impairment and those who remained stable.

## Limits and interpretation

Prediction performance does not show that triglycerides cause cognitive decline. The internal sample was small, and retrospective cohort results can reflect selection and measurement differences. The paper calls for prospective multicenter validation before clinical implementation.

## Sources

- [Prediction of cognitive impairment in Parkinson’s disease using TabPFN: an integrative analysis of clinical data, longitudinal trajectories, and lipidomics](https://doi.org/10.3389/fnagi.2026.1905374) — 2026-09-30
